by Eric Christianson | Apr 22, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Sean Navin is a clinical pharmacist who graduated in 2015 from my alma mater (University of Minnesota – Duluth). I’m excited to have him share his breakdown on Medications Targeting Pre- and Post-Prandial Glucose! You can track him down here. When managing...
by Eric Christianson | Feb 19, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
A compelling indication is simply another reason (typically a disease state) as to why you choose a medication. Compelling indications in diabetes are increasingly important in medication selection in diabetes. I lay out some of those reasons below. Metformin...
by Eric Christianson | Jan 26, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I recently received a text from a friend about the use of oral semaglutide in a patient with diabetes. It is definitely exciting to have more options for patients, even though we know there will inevitably be insurance coverage hurdles to jump through. Here are a few...
by Eric Christianson | Dec 22, 2019 | Endocrine Medication and Disease State Clinical Pearls, Long Term Care Consultant Pharmacist Education and Information, Medication and Disease State Clinical Pearls For Pharmacists
I’ve worked within the walls of numerous types of settings that have access to life-saving and life-threatening medications. Whether it be at a clinic, long term care facility, assisted living facility, or hospital, it can be easy for staff to have a cavalier...
by Eric Christianson | Dec 8, 2019 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
With the recent changes in the Beers Criteria, glimepiride has now been added to the list of sulfonylureas to avoid. Glipizide is the preferred agent if a sulfonylurea is to be used. This begs the question, should we recommend changing glimepiride to glipizide? In my...
by Eric Christianson | Nov 10, 2019 | Drug Interaction Case Studies and Education For Pharmacists, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t...
